Drug intelligence / Profile preview

betacarotene

Development stage
Unknown
Lead developer
Petrus Pharmaceuticals
Modality
Small Molecules
Administration
Oral
01

Overview

Betavit is a commercial consumer healthcare product developed and marketed by Petrus Pharmaceuticals, primarily in the Australian market. It is formulated as an oral capsule containing 6 mg of betacarotene, a provitamin A carotenoid. Betacarotene is a lipid-soluble pigment that the human body converts into Vitamin A (retinol) as needed, making it a safe source of the vitamin without the high risk of toxicity associated with preformed Vitamin A. It plays a critical role in maintaining ocular health, supporting the immune system, and promoting healthy skin and mucous membranes. Additionally, betacarotene acts as a potent antioxidant, neutralizing free radicals and protecting tissues from oxidative stress. In Australia, it is listed on the Australian Register of Therapeutic Goods (ARTG) as a complementary medicine for nutritional supplementation.

Brand names
Betavit
Other names
beta-caroteneprovitamin Abeta,beta-carotene
02

Targets

RARA (Retinoic acid receptor alpha)RARG (Retinoic acid receptor gamma)RARB (Retinoic acid receptor beta)RXRA (Retinoid X receptor alpha)

Beyond the preview

Go deeper on betacarotene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on betacarotene.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call